Ppeople will be able to access medicinal cannabis in Ireland in certain circumstances.
The Government announced it will fund the Medicinal Cannabis Access Programme, which was introduced into legislation in 2019.
The medicine will be available through a consultant for people suffering muscle spasms from MS, nausea and vomiting from chemotherapy or those who have severe epilepsy.
The first stage of the programme was to have potential suppliers apply to the Health Products Regulatory Authority (HPRA) to have their cannabis-based products assessed for suitability for medical use.
Currently four products have been assessed as acceptable by the HPRA. Further products are currently being assessed and if they are found to be acceptable, these products will be added to the schedule of products for inclusion in the programme.
Enrolment
The HSE will establish and maintain an electronic register for the Medical Cannabis Access Programme to facilitate the enrolment and recording of certain data including patient identifiers (in anonymised format), prescribers enrolled in the programme, as well as prescribed/supplied medical cannabis products.
Pending the commencement of the Access Programme clinicians and their patients have been availing of a licence under the Misuse of Drugs Acts 1977-2016 in order to prescribe and administer cannabis-based products. The commencement of the Access…
Original Author Link click here to read complete story..
Ppeople will be able to access medicinal cannabis in Ireland in certain circumstances.
The Government announced it will fund the Medicinal Cannabis Access Programme, which was introduced into legislation in 2019.
The medicine will be available through a consultant for people suffering muscle spasms from MS, nausea and vomiting from chemotherapy or those who have severe epilepsy.
The first stage of the programme was to have potential suppliers apply to the Health Products Regulatory Authority (HPRA) to have their cannabis-based products assessed for suitability for medical use.
Currently four products have been assessed as acceptable by the HPRA. Further products are currently being assessed and if they are found to be acceptable, these products will be added to the schedule of products for inclusion in the programme.
Enrolment
The HSE will establish and maintain an electronic register for the Medical Cannabis Access Programme to facilitate the enrolment and recording of certain data including patient identifiers (in anonymised format), prescribers enrolled in the programme, as well as prescribed/supplied medical cannabis products.
Pending the commencement of the Access Programme clinicians and their patients have been availing of a licence under the Misuse of Drugs Acts 1977-2016 in order to prescribe and administer cannabis-based products. The commencement of the Access…
